Navigation Links
Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
Date:9/16/2010

SAN DIEGO, and WOODCLIFF LAKE, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 9 to 5 that the available data do not adequately demonstrate that the potential benefits of lorcaserin outweigh the potential risks, when used long-term in a population of overweight and obese individuals to allow marketing approval. Lorcaserin, which Arena discovered and has developed, is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (Body Mass Index, or BMI, >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.

"We believe that lorcaserin has a positive benefit-risk profile and represents a potential advance in the treatment of obesity," said Jack Lief, Arena's President and Chief Executive Officer. "We will work with the FDA as the agency completes its review of the lorcaserin new drug application."  

Although advisory committees provide recommendations to the FDA, the agency makes the final decisions. The FDA has assigned a PDUFA date, the target date for the agency to complete its review of the lorcaserin New Drug Application (NDA), of October 22, 2010.

Conference Call & Webcast Arena will host a conference call and webcast tomorrow, September 17, 2010, at 7:00 a.m. Eastern Time (4:00 a.m. Pacific Time). The conference call may be accessed by dialing 877.303.6132 for domestic callers and 678.809.1062 for international callers. Please specify to the operator that you would like to join the "Lorcaserin" conference call. The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com,
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 CTI BioPharma Corp. (CTI) (NASDAQ ... its second quarter 2014 financial results on Monday, August ... markets. Following the announcement, members of the management team ... results and provide a general corporate update at 4:30 ... can be obtained as follows: Monday, August ...
(Date:7/25/2014)... 25, 2014  Corporate libraries are constantly being faced ... in technology and how to cope with flat or ... pharmaceutical and medical device industries are increasingly finding it ... services they provide. According to recent ... many forces of change that leading corporate libraries are ...
(Date:7/25/2014)...  Depomed, Inc. (NASDAQ: DEPO ) today ... 2014 financial results after the market closes on Wednesday, August ... beginning at 4:30 pm EDT, 1:30 pm PDT to discuss its ... dialing 877-317-6789 ( United States ) or ... via a live webcast on the investor relations section ...
Breaking Medicine Technology:CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 2Forces of Change Reshaping Corporate Libraries & Information Services 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2
... N.C., March 4, 2011 The pressure for a ... greater with organizations across the pharmaceutical sector facing pipeline ... Facing an ever-changing launch landscape, product launch leaders ... new therapies through the labyrinth of regulatory and marketplace ...
... 2011 Cardica, Inc. (Nasdaq: CRDC ) ... stapling device developed by Cardica has received CE Mark ... marking process, Cardica has obtained a Full Quality Assurance ... this certification, after successful completion of development, Cardica can ...
Cached Medicine Technology:Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map 2Cardica Receives European CE Mark for Initial Microcutter™ Surgical Cutting and Stapling Device 2Cardica Receives European CE Mark for Initial Microcutter™ Surgical Cutting and Stapling Device 3Cardica Receives European CE Mark for Initial Microcutter™ Surgical Cutting and Stapling Device 4
(Date:7/28/2014)... A common inflammatory muscle disorder that causes pain ... risk for heart attack and stroke, new ... patients with polymyalgia rheumatica are more likely to ... blood vessels. Doctors should carefully manage the vascular ... reduce their risk for complications, the study authors ...
(Date:7/28/2014)... A new study, published in the July, 2014, ... Cancer Institute by Northwestern Medicine researchers, sheds ... growing popularity of endoscopic resection in the treatment ... the more traditional surgical resection, while more invasive, ... five-year survival rate for patients than endoscopic resection, ...
(Date:7/28/2014)... Jose, CA (PRWEB) July 28, 2014 ... family life Americans face today, BlogHer, The Center for ... to launch “Make Life Work,” a campaign to raise ... by families across the U.S. The joint initiative was ... Stacy Morrison, Editor-in-Chief, BlogHer; Judith Warner, Senior Fellow, The ...
(Date:7/28/2014)... 2014 The website, which is hosted ... industry, went live in January 2014. The honor recognizes ... of excellence that comprise the web’s most professional work. ... , “What pleases me the most is that we ... categories,” said Joshua Snow, web manager, Abington Health. “We ...
(Date:7/28/2014)... Synergy Business Solutions announced today it was chosen ... list of top 100 value added resellers (VAR) of ... is the eighth year since 2006 that Synergy has ... success in terms of revenue, growth, and accounting software ... to be counted among such a reputable list of ...
Breaking Medicine News(10 mins):Health News:Inflammatory Muscle Disorder May Raise Risk for Heart Attack, Stroke 2Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 4Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 5Health News:Abington Health Website Named Best in Class 2Health News:Synergy Business Solutions Selected to Top 100 VAR List for Eighth Year by Accounting Today 2Health News:Synergy Business Solutions Selected to Top 100 VAR List for Eighth Year by Accounting Today 3
... ... of the myESMO Professional Networking Community, an innovative online platform that offers society members ... ... European Society for Medical Oncology is today pleased to announce the launch of ...
... AWF calls on Gov. Parkinson to condemn and abandon such practices ... Alliance for Worker Freedom (AWF) calls on Kansas Governor Mark Parkinson ... resources and taxpayer money to obtain personal contact information of healthcare ... Kansas. , , Letters obtained by AWF, printed ...
... , SHENZHEN, China, Sept. 14 /PRNewswire-FirstCall/ - HTDS ... following update to its shareholders and followers on the ... subsidiary and other general business matters. , At the ... of Influenza A (H1N1) Vaccine (Split Virion). The company ...
... A popular stomach-acid reducer used to prevent stress ... increases the risk of those patients contracting pneumonia threefold, ... Medicine. Hospital-acquired pneumonia is the leading cause of ... stays by an average of seven to nine days, ...
... , LAS VEGAS, Sept. 14 EQ Labs, Inc. ... the Company held its first public stockholders, meeting at its headquarters ... of the Board and CEO presiding. The Board of Directors ... recommendations of the Board and the resolutions placed before the shareholders ...
... Sept. 14 Tupperware Brands Corporation,s highly successful Chain of ... to celebrate the importance of female friendship and the rewards that ... with organizations in local markets around the world who work to ... , , On September 17, 2009 ...
Cached Medicine News:Health News:ESMO Online Innovation Helps the Oncology Community Share Knowledge and Enhance Practice 2Health News:ESMO Online Innovation Helps the Oncology Community Share Knowledge and Enhance Practice 3Health News:ESMO Online Innovation Helps the Oncology Community Share Knowledge and Enhance Practice 4Health News:Kansas Departments Use Taxpayer Money and State Resources to Collect Healthcare Workers' Names for the SEIU 2Health News:Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production 2Health News:Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production 3Health News:Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production 4Health News:Popular stomach acid reducer triples risk of developing pneumonia 2Health News:EQLB Releases Letter to Shareholders 2Health News:EQLB Releases Letter to Shareholders 3Health News:BeautiControl(R) Encompasses Tupperware Brands Global Women's Initiative: Chain of Confidence(R) 2
The Advance Unicompartmental Knee System is designed with bone conserving femoral and tibial components that provide reproducible results within a minimal incision. Uni metal backed tibial component....
...
...
... Severe revision options for the knee and ... modular system for the knee and hip ... that include surgical indication, implant selection, connection ... individual needs. This system addresses the needs ...
Medicine Products: